Clinical trial
A Study of Rofecoxib in the Treatment of Post-Operative Pain After Total Knee…
NCT00140920 · Merck Sharp & Dohme LLC, Industry · Terminated
Key facts
| NCT number | NCT00140920 |
|---|---|
| Title | A Study of Rofecoxib in the Treatment of Post-Operative Pain After Total Knee Joint Replacement (0966-259) |
| Official title | A Study to Compare Pre-Operative Administration of Rofecoxib Vs Post-Operative Administration of Diclofenac or Rofecoxib in the Treatment of Post-Operative Pain After Total Knee Joint Replacement in Patients With Osteoarthritis of the Knee. |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | MK0966, rofecoxib, Comparator: diclofenac 2x 75 mg |
| Enrollment | 11 |
| Start date | May 25, 2004 |
| Primary completion | Sep 27, 2004 |
| Completion | Sep 27, 2004 |
| First posted | Sep 1, 2005 |
| Last update posted | May 9, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: